Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0791
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Total Copy Number Variation as a Prognostic Factor in Adult Astrocytoma Subtypes

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2019English

623 CRD-BP as a Potential Prognostic Marker and Therapeutic Target in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Prognostic Metabolic Markers in Cutaneous Melanoma

British Journal of Dermatology
DermatologyMedicine
2019English

Erratum To: Progression of Cutaneous Melanoma: Implications for Treatment

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2012English

PHIP as a Therapeutic Target for Driver-Negative Subtypes of Melanoma, Breast, and Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Germline DNA Copy Number Aberrations Identified as Potential Prognostic Factors for Breast Cancer Recurrence

PLoS ONE
Multidisciplinary
2013English

Prognostic Value of B Cells in Cutaneous Melanoma

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2019English

Prognostic Survival Model for People Diagnosed With Invasive Cutaneous Melanoma

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Prognostic Impact of P62 Expression in Cutaneous Malignant Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy